Abbott | ABT - Net Income

Stock Price
92.85
Daily Change
1.72 1.89%
Monthly
-8.86%
Yearly
-28.32%
Q2 Forecast
89.18

Abbott reported $1.08B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Agilent USD 305M 129M Dec/2025
AtriCure USD 1.76M 2.02M Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Bio-Rad Laboratories USD -341.9M 659.7M Sep/2025
Boston Scientific USD 1.34B 669M Mar/2026
Cooper Companies USD 130.8M 46.2M Dec/2025
Danaher USD 1.03B 168M Mar/2026
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -1.7M 3.7M Dec/2025
Intuitive Surgical USD 821.5M 26.7M Mar/2026
J&J USD 5.24B 119M Mar/2026
Masimo USD 68.3M 168.7M Dec/2025
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Smith & Nephew USD 293M 79M Dec/2025
Solventum Corp USD 63M 1.2B Dec/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
Terumo JPY 32.65B 2.4B Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025